Exelixis Inc. (NASDAQ:EXEL) finished Thursday with an addition of $0.26 to close at $22.01, an upside of 1.20 percent. An average of 1,697,127 shares of common stock have been traded in the last five days. There was a gain of $0.90 in the past week, and it reached a new high 17 times over the past 12 months. The last 20 days have seen an average of 2,404,712 shares traded, while the 50-day average volume stands at 2,407,091.
EXEL stock has increased by 12.30% in the last month. The company shares reached their 1-month lowest point of $19.50 on 07/31/23. With the stock rallying to its 52-week high on 08/24/23, shares of the company touched a low of $14.87 and a high of $22.15 in 52 weeks. It has reached a new high 24 times so far this year and achieved 37.23% or $5.95 in price. In spite of this, the price is down -0.60% from the 52-week high.
Insider Transactions
EXEL stock investors should be aware that Exelixis Inc. (EXEL) stock had its last reported insider trading activity 21 days ago on Aug 04. In this transaction, the insider spent $1,240,800. EVP and CFO, Senner Christopher J., disposed of 60,000 shares at a price of $20.51 on Aug 03. The insider now owns more than $1,230,600 worth of shares. Prior to that, EVP, Commercial Haley Patrick J. went on to Sale 30,553 shares at $20.67 each on Aug 03. An amount of $631,531 was transacted.
Valuation Metrics
Exelixis Inc. (EXEL) has a trailing price-to-earnings (P/E) ratio of 43.76. The stock’s beta is 0.64. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.07, the price-to-book (PB) ratio at 2.82, and the price-to-cash flow ratio at 19.29.
Financial Health
The quick ratio of Exelixis Inc. for the three months ended June 29 was 4.60, and the current ratio was 4.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $1.55 billion compared to revenue of $1.61 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Exelixis Inc.’s return on assets was 5.30%.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $81.18 million in the quarter, while revenues were grew 12.95%. The analyst consensus anticipated Exelixis Inc.’s latest quarter earnings to come in at $0.16 per share, but it turned out to be $0.25, a 56.20% surprise. For the quarter, EBITDA amounted to $83.89 million. Shareholders own equity worth $318.38 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Exelixis Inc. (EXEL) price momentum. RSI 9-day as of the close on 24 August was 75.80%, suggesting the stock is Overbought, with historical volatility in this time frame at 14.79%.
As of today, EXEL’s price is $21.67 +4.24% or $0.90 from its 5-day moving average. EXEL is currently trading +10.81% higher than its 20-day SMA and +12.91% higher than its 100-day SMA. However, the stock’s current price level is +17.12% above the SMA50 and +34.53% above the SMA200.
The stochastic %K and %D were 90.70% and 88.53%, respectively, and the average true range (ATR) was 0.36. With the 14-day stochastic at 92.94% and the average true range at 0.37, the RSI (14) stands at 71.92%. The stock has reached 0.35 on the 9-day MACD Oscillator while the 14-day reading was at 0.50.
Analyst Ratings
Oppenheimer reiterated its an Outperform rating on Exelixis Inc. (NASDAQ: EXEL), but raised their price target to $25, indicating a potential price increase of 11.96% for the stock. The consensus rating for Exelixis Inc. (EXEL) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell EXEL, while 4 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 12 others rate it as a “buy”.
What is EXEL’s price target for the next 12 months?
Analysts predict a range of price targets between $18.00 and $32.00, with a median target of $25.50. Taking a look at these predictions, the average price target given by analysts for Exelixis Inc. (EXEL) stock is $25.00.
